Loading…

Treatment of Congenital Melanocytic Nevi With a Dual-Wavelengths Copper Vapor Laser: A Case Series

Introduction: Congenital melanocytic nevus (CMN) is a severe challenge for dermatology. This pigmented skin lesion is undesirable for patients because of its localization in open areas of the body. Various visible and near-infrared laser systems and intense pulsed light (IPL) sources have been appli...

Full description

Saved in:
Bibliographic Details
Published in:Journal of lasers in medical sciences 2021-02, Vol.12, p.e5-e5
Main Authors: Ponomarev, Igor V., Topchiy, Sergey B., Pushkareva, Alexandra E., Klyuchareva, Svetlana V., Andrusenko, Yury N.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c331t-650acbd50243992f2e5cf26ca9170ae714ca0fd75b9269121713b3ea972b748f3
cites
container_end_page e5
container_issue
container_start_page e5
container_title Journal of lasers in medical sciences
container_volume 12
creator Ponomarev, Igor V.
Topchiy, Sergey B.
Pushkareva, Alexandra E.
Klyuchareva, Svetlana V.
Andrusenko, Yury N.
description Introduction: Congenital melanocytic nevus (CMN) is a severe challenge for dermatology. This pigmented skin lesion is undesirable for patients because of its localization in open areas of the body. Various visible and near-infrared laser systems and intense pulsed light (IPL) sources have been applied for CMN treatment. However, post-traumatic hyperpigmentation, structural changes, atrophy, and scarring due to non-specific thermal damage have been observed. Many patients have shown recurrence after treatment. Therefore, it highlights the need for testing new laser modalities for the management of CMN. Methods: Two adult II Fitzpatrick phototype patients (a 55-year-old male and a 30-year-old female) with middle-sized facial CMN (on the forehead and lower eyelid) are presented. All patients were treated with dual-wavelength copper vapor laser (CVL) radiation at 511 nm and 578 nm wavelengths with a power ratio of 3:2. The average power was 0.7-0.85 W with an exposure time of 0.3 seconds. The spot size amounted to 1 mm. Results: Both patients showed complete resolution of CMN after CVL treatments. CMN became crusted within a few days after the laser treatment and peeled off within seven days. No recurrences were observed during the follow-up period up to 24 months. Conclusion: The middle-sized CMN can be successfully treated with dual-wavelength CVL radiation.
doi_str_mv 10.34172/jlms.2021.05
format article
fullrecord <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8164897</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_8164897</sourcerecordid><originalsourceid>FETCH-LOGICAL-c331t-650acbd50243992f2e5cf26ca9170ae714ca0fd75b9269121713b3ea972b748f3</originalsourceid><addsrcrecordid>eNpVkE1Lw0AQhhdRbKk9et8_kLpfyWY9CKV-QtWD1R6XyXbSpuSL3bTQf29qRXAu88LwPjAPIdecTaTiWtxsyypMBBN8wuIzMhRCpFGiBT_vM2NpZHQqB2Qcwpb1o5lUwlySgVQsVVryIckWHqGrsO5ok9NZU6-xLjoo6SuWUDfu0BWOvuG-oMui21Cg9zsooyXsscR63W1C32lb9PQL2sbTOQT0t3RKZ32gH-gLDFfkIocy4Ph3j8jn48Ni9hzN359eZtN55KTkXZTEDFy2iplQ0hiRC4xdLhIHhmsGqLlywPKVjjMjEsMF11xmEsFokWmV5nJE7k7cdpdVuHL9Tx5K2_qiAn-wDRT2_6UuNnbd7G3KE5Ua3QOiE8D5JgSP-V-XM_vj2x5926Nvy2L5De9Fcv4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Treatment of Congenital Melanocytic Nevi With a Dual-Wavelengths Copper Vapor Laser: A Case Series</title><source>NCBI_PubMed Central(免费)</source><creator>Ponomarev, Igor V. ; Topchiy, Sergey B. ; Pushkareva, Alexandra E. ; Klyuchareva, Svetlana V. ; Andrusenko, Yury N.</creator><creatorcontrib>Ponomarev, Igor V. ; Topchiy, Sergey B. ; Pushkareva, Alexandra E. ; Klyuchareva, Svetlana V. ; Andrusenko, Yury N.</creatorcontrib><description>Introduction: Congenital melanocytic nevus (CMN) is a severe challenge for dermatology. This pigmented skin lesion is undesirable for patients because of its localization in open areas of the body. Various visible and near-infrared laser systems and intense pulsed light (IPL) sources have been applied for CMN treatment. However, post-traumatic hyperpigmentation, structural changes, atrophy, and scarring due to non-specific thermal damage have been observed. Many patients have shown recurrence after treatment. Therefore, it highlights the need for testing new laser modalities for the management of CMN. Methods: Two adult II Fitzpatrick phototype patients (a 55-year-old male and a 30-year-old female) with middle-sized facial CMN (on the forehead and lower eyelid) are presented. All patients were treated with dual-wavelength copper vapor laser (CVL) radiation at 511 nm and 578 nm wavelengths with a power ratio of 3:2. The average power was 0.7-0.85 W with an exposure time of 0.3 seconds. The spot size amounted to 1 mm. Results: Both patients showed complete resolution of CMN after CVL treatments. CMN became crusted within a few days after the laser treatment and peeled off within seven days. No recurrences were observed during the follow-up period up to 24 months. Conclusion: The middle-sized CMN can be successfully treated with dual-wavelength CVL radiation.</description><identifier>ISSN: 2008-9783</identifier><identifier>EISSN: 2228-6721</identifier><identifier>DOI: 10.34172/jlms.2021.05</identifier><identifier>PMID: 34084731</identifier><language>eng</language><publisher>Laser Application in Medical Sciences Research Center</publisher><subject>Case Series</subject><ispartof>Journal of lasers in medical sciences, 2021-02, Vol.12, p.e5-e5</ispartof><rights>Copyright © 2021 J Lasers Med Sci 2021</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c331t-650acbd50243992f2e5cf26ca9170ae714ca0fd75b9269121713b3ea972b748f3</citedby><orcidid>0000-0003-0801-6181 ; 0000-0002-3683-2672 ; 0000-0002-3345-3482 ; 0000-0003-0082-984X ; 0000-0001-6540-9235</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164897/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164897/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Ponomarev, Igor V.</creatorcontrib><creatorcontrib>Topchiy, Sergey B.</creatorcontrib><creatorcontrib>Pushkareva, Alexandra E.</creatorcontrib><creatorcontrib>Klyuchareva, Svetlana V.</creatorcontrib><creatorcontrib>Andrusenko, Yury N.</creatorcontrib><title>Treatment of Congenital Melanocytic Nevi With a Dual-Wavelengths Copper Vapor Laser: A Case Series</title><title>Journal of lasers in medical sciences</title><description>Introduction: Congenital melanocytic nevus (CMN) is a severe challenge for dermatology. This pigmented skin lesion is undesirable for patients because of its localization in open areas of the body. Various visible and near-infrared laser systems and intense pulsed light (IPL) sources have been applied for CMN treatment. However, post-traumatic hyperpigmentation, structural changes, atrophy, and scarring due to non-specific thermal damage have been observed. Many patients have shown recurrence after treatment. Therefore, it highlights the need for testing new laser modalities for the management of CMN. Methods: Two adult II Fitzpatrick phototype patients (a 55-year-old male and a 30-year-old female) with middle-sized facial CMN (on the forehead and lower eyelid) are presented. All patients were treated with dual-wavelength copper vapor laser (CVL) radiation at 511 nm and 578 nm wavelengths with a power ratio of 3:2. The average power was 0.7-0.85 W with an exposure time of 0.3 seconds. The spot size amounted to 1 mm. Results: Both patients showed complete resolution of CMN after CVL treatments. CMN became crusted within a few days after the laser treatment and peeled off within seven days. No recurrences were observed during the follow-up period up to 24 months. Conclusion: The middle-sized CMN can be successfully treated with dual-wavelength CVL radiation.</description><subject>Case Series</subject><issn>2008-9783</issn><issn>2228-6721</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVkE1Lw0AQhhdRbKk9et8_kLpfyWY9CKV-QtWD1R6XyXbSpuSL3bTQf29qRXAu88LwPjAPIdecTaTiWtxsyypMBBN8wuIzMhRCpFGiBT_vM2NpZHQqB2Qcwpb1o5lUwlySgVQsVVryIckWHqGrsO5ok9NZU6-xLjoo6SuWUDfu0BWOvuG-oMui21Cg9zsooyXsscR63W1C32lb9PQL2sbTOQT0t3RKZ32gH-gLDFfkIocy4Ph3j8jn48Ni9hzN359eZtN55KTkXZTEDFy2iplQ0hiRC4xdLhIHhmsGqLlywPKVjjMjEsMF11xmEsFokWmV5nJE7k7cdpdVuHL9Tx5K2_qiAn-wDRT2_6UuNnbd7G3KE5Ua3QOiE8D5JgSP-V-XM_vj2x5926Nvy2L5De9Fcv4</recordid><startdate>20210214</startdate><enddate>20210214</enddate><creator>Ponomarev, Igor V.</creator><creator>Topchiy, Sergey B.</creator><creator>Pushkareva, Alexandra E.</creator><creator>Klyuchareva, Svetlana V.</creator><creator>Andrusenko, Yury N.</creator><general>Laser Application in Medical Sciences Research Center</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0801-6181</orcidid><orcidid>https://orcid.org/0000-0002-3683-2672</orcidid><orcidid>https://orcid.org/0000-0002-3345-3482</orcidid><orcidid>https://orcid.org/0000-0003-0082-984X</orcidid><orcidid>https://orcid.org/0000-0001-6540-9235</orcidid></search><sort><creationdate>20210214</creationdate><title>Treatment of Congenital Melanocytic Nevi With a Dual-Wavelengths Copper Vapor Laser: A Case Series</title><author>Ponomarev, Igor V. ; Topchiy, Sergey B. ; Pushkareva, Alexandra E. ; Klyuchareva, Svetlana V. ; Andrusenko, Yury N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c331t-650acbd50243992f2e5cf26ca9170ae714ca0fd75b9269121713b3ea972b748f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Case Series</topic><toplevel>online_resources</toplevel><creatorcontrib>Ponomarev, Igor V.</creatorcontrib><creatorcontrib>Topchiy, Sergey B.</creatorcontrib><creatorcontrib>Pushkareva, Alexandra E.</creatorcontrib><creatorcontrib>Klyuchareva, Svetlana V.</creatorcontrib><creatorcontrib>Andrusenko, Yury N.</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of lasers in medical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ponomarev, Igor V.</au><au>Topchiy, Sergey B.</au><au>Pushkareva, Alexandra E.</au><au>Klyuchareva, Svetlana V.</au><au>Andrusenko, Yury N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of Congenital Melanocytic Nevi With a Dual-Wavelengths Copper Vapor Laser: A Case Series</atitle><jtitle>Journal of lasers in medical sciences</jtitle><date>2021-02-14</date><risdate>2021</risdate><volume>12</volume><spage>e5</spage><epage>e5</epage><pages>e5-e5</pages><issn>2008-9783</issn><eissn>2228-6721</eissn><abstract>Introduction: Congenital melanocytic nevus (CMN) is a severe challenge for dermatology. This pigmented skin lesion is undesirable for patients because of its localization in open areas of the body. Various visible and near-infrared laser systems and intense pulsed light (IPL) sources have been applied for CMN treatment. However, post-traumatic hyperpigmentation, structural changes, atrophy, and scarring due to non-specific thermal damage have been observed. Many patients have shown recurrence after treatment. Therefore, it highlights the need for testing new laser modalities for the management of CMN. Methods: Two adult II Fitzpatrick phototype patients (a 55-year-old male and a 30-year-old female) with middle-sized facial CMN (on the forehead and lower eyelid) are presented. All patients were treated with dual-wavelength copper vapor laser (CVL) radiation at 511 nm and 578 nm wavelengths with a power ratio of 3:2. The average power was 0.7-0.85 W with an exposure time of 0.3 seconds. The spot size amounted to 1 mm. Results: Both patients showed complete resolution of CMN after CVL treatments. CMN became crusted within a few days after the laser treatment and peeled off within seven days. No recurrences were observed during the follow-up period up to 24 months. Conclusion: The middle-sized CMN can be successfully treated with dual-wavelength CVL radiation.</abstract><pub>Laser Application in Medical Sciences Research Center</pub><pmid>34084731</pmid><doi>10.34172/jlms.2021.05</doi><orcidid>https://orcid.org/0000-0003-0801-6181</orcidid><orcidid>https://orcid.org/0000-0002-3683-2672</orcidid><orcidid>https://orcid.org/0000-0002-3345-3482</orcidid><orcidid>https://orcid.org/0000-0003-0082-984X</orcidid><orcidid>https://orcid.org/0000-0001-6540-9235</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2008-9783
ispartof Journal of lasers in medical sciences, 2021-02, Vol.12, p.e5-e5
issn 2008-9783
2228-6721
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8164897
source NCBI_PubMed Central(免费)
subjects Case Series
title Treatment of Congenital Melanocytic Nevi With a Dual-Wavelengths Copper Vapor Laser: A Case Series
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T05%3A05%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20Congenital%20Melanocytic%20Nevi%20With%20a%20Dual-Wavelengths%20Copper%20Vapor%20Laser:%20A%20Case%20Series&rft.jtitle=Journal%20of%20lasers%20in%20medical%20sciences&rft.au=Ponomarev,%20Igor%20V.&rft.date=2021-02-14&rft.volume=12&rft.spage=e5&rft.epage=e5&rft.pages=e5-e5&rft.issn=2008-9783&rft.eissn=2228-6721&rft_id=info:doi/10.34172/jlms.2021.05&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_8164897%3C/pubmedcentral_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c331t-650acbd50243992f2e5cf26ca9170ae714ca0fd75b9269121713b3ea972b748f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/34084731&rfr_iscdi=true